Keppra — Class II drug recall D-1838-2019
Terminated recall by Ucb, Inc, reported 2019-07-31, distributed in TN. Failed Dissolution Specifications.
| Recall number | D-1838-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ucb, Inc, Smyrna, GA, United States |
| Recall initiated | 2019-07-18 |
| Classified | 2019-08-21 |
| Reported by FDA | 2019-07-31 |
| Terminated | 2020-01-24 |
| Distributed | TN |
| Quantity | 2,088 bottles |
| Reason classes | specification failure |
| NDC | 50474-0001, 50474-0001-48, 50474-0594, 50474-0594-40, 50474-0595, 50474-0595-40, 50474-0596, 50474-0596-40, 50474-0597, 50474-0597-66 |
| Lot numbers | 908946 |
| Expiration dates | 2022-02 |
Product
Keppra (levetiracetam) 1000 mg tablets, 60 tablets per bottle, Rx only, Manufactured for UCB, Inc. Smyrna, GA 30080, NDC 50474-597-66.
Reason for recall
Failed Dissolution Specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1838-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.